|
1
|
Sivanathan V, Kittner JM, Sprinzl MF,
Weinmann A, Koch S, Wiltink J, Nguyen-Tat M, Marquardt JU, Wörns
MA, Zimmermann T, et al: Etiology and complications of liver
cirrhosis: Data from a German centre. Dtsch Med Wochenschr.
139:1758–1762. 2014.(In German). PubMed/NCBI
|
|
2
|
Silva MJ, Rosa MV, Nogueira PJ and Calinas
F: Ten years of hospital admissions for liver cirrhosis in
portugal. Eur J Gastroenterol Hepatol. 27:1320–1326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qua CS and Goh KL: Liver cirrhosis in
Malaysia: peculiar epidemiology in a multiracial Asian country. J
Gastroenterol Hepatol. 26:1333–1337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mokdad AA, Lopez AD, Shahraz S, Lozano R,
Mokdad AH, Stanaway J, Murray CJ and Naghavi M: Liver cirrhosis
mortality in 187 countries between 1980 and 2010: A systematic
analysis. BMC Med. 12:1452014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sandhu BS and Sanyal AJ: Management of
ascites in cirrhosis. Clin Liver Dis. 9:715–732, viii. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Runyon BA; AASLD Practice Guidelines
Committee, : Management of adult patients with ascites due to
cirrhosis: An update. Hepatology. 49:2087–2107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Planas R, Montoliu S, Ballesté B, Rivera
M, Miquel M, Masnou H, Galeras JA, Giménez MD, Santos J, Cirera I,
et al: Natural history of patients hospitalized for management of
cirrhotic ascites. Clin Gastroenterol Hepatol. 4:1385–1394. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salerno F, Cammà C, Enea M, Rössle M and
Wong F: Transjugular intrahepatic portosystemic shunt for
refractory ascites: A meta-analysis of individual patient data.
Gastroenterology. 133:825–834. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garcia-Tsao G: Current management of the
complications of cirrhosis and portal hypertension: Variceal
hemorrhage, ascites, and spontaneous bacterial peritonitis.
Gastroenterology. 120:726–748. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sabri M, Saps M and Peters JM:
Pathophysiology and management of pediatric ascites. Curr
Gastroenterol Rep. 5:240–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Witte MH, Witte CL and Dumont AE: Progress
in liver disease: Physiological factors involved in the causation
of cirrhotic ascites. Gastroenterology. 61:742–750. 1971.PubMed/NCBI
|
|
12
|
Levick JR and Michel CC: Microvascular
fluid exchange and the revised Starling principle. Cardiovasc Res.
87:198–210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wongcharatrawee S and Garcia-Tsao G:
Clinical management of ascites and its complications. Clin Liver
Dis. 5:833–850. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schrier RW: Pathogenesis of sodium and
water retention in high-output and low-output cardiac failure,
nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med.
319:1127–1134. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Levy M and Wexler MJ: Hepatic denervation
alters first-phase urinary sodium excretion in dogs with cirrhosis.
Am J Physiol. 253:F664–F671. 1987.PubMed/NCBI
|
|
16
|
Kostreva DR, Castaner A and Kampine JP:
Reflex effects of hepatic baroreceptors on renal and cardiac
sympathetic nerve activity. Am J Physiol. 238:R390–R394.
1980.PubMed/NCBI
|
|
17
|
Schrier RW, Arroyo V, Bernardi M, Epstein
M, Henriksen JH and Rodés J: Peripheral arterial vasodilation
hypothesis: A proposal for the initiation of renal sodium and water
retention in cirrhosis. Hepatology. 8:1151–1157. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Donati G, Piscaglia F, Coli L, Silvagni E,
Righini R, Donati G, Pini P, Stefoni S and Bolondi L: Acute
systemic, splanchnic and renal haemodynamic changes induced by
molecular adsorbent recirculating system (MARS) treatment in
patients with end-stage cirrhosis. Aliment Pharmacol Ther.
26:717–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Catalina MV, Barrio J, Anaya F, Salcedo M,
Rincón D, Clemente G and Bañares R: Hepatic and systemic
haemodynamic changes after MARS in patients with acute on chronic
liver failure. Liver Int. 23 Suppl 3:S39–S43. 2003. View Article : Google Scholar
|
|
20
|
Jiang SM, Zhou GW, Shen C, Yan JQ, Wan L,
Li QY, Yang WP, Shen BY, Chen H, Peng CH and Li HW: A clinical
study on splanchnic hemodynamic changes after orthotopic liver
transplantation for patients with portal hypertension. Zhonghua Wai
Ke Za Zhi. 46:1699–1702. 2008.(In Chinese). PubMed/NCBI
|
|
21
|
Helen MN and Newcomer ME: The structure of
human retinol binding protein (RBP) with its carrier protein
transthyretin reveals an interaction with the carboxy terminus of
RBP. Biochemistry. 38:2647–2653. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Monaco HL, Rizzi M and Coda A: Structure
of a complex of two plasma proteins: Transthyretin and
retinol-binding protein. Science. 268:1039–1041. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chantrel F, Agin A, Offner M, Koehl C,
Moulin B and Hannedouche T: Comparison of cystatin C versus
creatinine for detection of mild renal failure. Clin Nephrol.
54:374–381. 2000.PubMed/NCBI
|
|
24
|
Fukui H, Saito H, Ueno Y, Uto H, Obara K,
Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, et al:
Evidence-based clinical practice guidelines for liver cirrhosis
2015. J Gastroenterol. 51:629–650. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
European Association for the Study of the
Liver, . EASL clinical practice guidelines on the management of
ascites, spontaneous bacterial peritonitis, and hepatorenal
syndromeincirrhosis. J Hepatol. 53:397–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Delanaye P and Mariat C: The applicability
of eGFR equations to different opulations. Nat Rev Nephrol.
9:513–522. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghassemi S and Garcia-Tsao G: Prevention
and treatment of infections in patients with cirrhosis. Best Pract
Res Clin Gastroenterol. 21:77–93. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ozdamar SO, Gucer S and Tinaztepe K:
Hepatitis-B virus associated nephropathies: A clinicopathological
study in 14 children. Pediatr Nephrol. 18:23–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Trawalé JM, Paradis V, Rautou PE, Francoz
C, Escolano S, Sallée M, Durand F, Valla D, Lebrec D and Moreau R:
The spectrum of renal lesions in patients with cirrhosis: A
clinicopathological study. Liver Int. 30:725–732. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou Y, Dong Q, Zhang R, Zhou S, Li L,
Cheng K, Kong R, Yu Q, Xu S, Li J, et al: Cerebral hemodynamics and
cognitive function in cirrhotic patients with hepatic
encephalopathy. Gastroenterol Res Pract. 2016:84850322016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu L, Dai W, Li J, He L, Wang F, Xia Y,
Chen K, Li S, Liu T, Lu J, et al: Methylation-regulated miR-124-1
suppresses tumorigenesis in hepatocellular carcinoma by targeting
CASC3. Oncotarget. 7:26027–26041. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang J, Li J, Dai W, Wang F, Shen M, Chen
K, Cheng P, Zhang Y, Wang C, Zhu R, et al: Golgi protein 73 as a
biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.
Exp Ther Med. 9:1413–1420. 2015.PubMed/NCBI
|
|
33
|
Liu Z, Wang J, Guo C and Fan X:
microRNA-21 mediates epithelial-mesenchymal transition of human
hepatocytes via PTEN/Akt pathway. Biomed Pharmacother. 69:24–28.
2015. View Article : Google Scholar : PubMed/NCBI
|
